Terms: = Kidney tumors AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD
35133 results:
1. kidney transplantation in patients with tuberous sclerosis complex.
Goedken AM; Ismail WW; Barrett LDG; Harshman LA
Pediatr Transplant; 2024 Jun; 28(4):e14765. PubMed ID: 38778713
[TBL] [Abstract] [Full Text] [Related]
2. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients.
Morra S; Incesu RB; Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Creta M; Califano G; Collà Ruvolo C; Saad F; Shariat SF; Chun FKH; de Cobelli O; Musi G; Briganti A; Tilki D; Ahyai S; Carmignani L; Longo N; Karakiewicz PI
World J Urol; 2024 May; 42(1):343. PubMed ID: 38775841
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the Treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study.
Hai L; Liu S; Ma L; Ding X; Bai X; Luo X
Technol Cancer Res Treat; 2024; 23():15330338241250315. PubMed ID: 38773767
[No Abstract] [Full Text] [Related]
4. Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.
Wang H; Liu Y; Tang A; Zhang X
Eur J Med Res; 2024 May; 29(1):292. PubMed ID: 38773560
[TBL] [Abstract] [Full Text] [Related]
5. The effect of unusual presentation on delayed diagnosis of prostate cancer: a case series.
Oyortey MA; Adanu KK; Ali MA
J Med Case Rep; 2024 May; 18(1):256. PubMed ID: 38773554
[TBL] [Abstract] [Full Text] [Related]
6. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of predictive factors for non-adherence to organized screening for colorectal and breast cancers in the pre-pandemic period (2018-2019) in Lombardy Region (Northern Italy)].
Russo AG; Murtas R; Ballotari P; Cavalieri d'Oro L; Gambino ML; Fanetti AC; Maifredi G; Manzoni F; Sampietro G; Leoni O; Celata C; Cereda D; Deandrea S;
Epidemiol Prev; 2024; 48(2):118-129. PubMed ID: 38770729
[TBL] [Abstract] [Full Text] [Related]
8. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
Sarabu N; Dong W; Koroukian SM
Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
[TBL] [Abstract] [Full Text] [Related]
9. Three-dimensional virtual model for robot-assisted partial nephrectomy: a propensity-score matching analysis with a contemporary control group.
Grosso AA; Di Maida F; Lambertini L; Cadenar A; Coco S; Ciaralli E; Salamone V; Vittori G; Tuccio A; Mari A; Ludovico GM; Minervini A
World J Urol; 2024 May; 42(1):338. PubMed ID: 38767673
[TBL] [Abstract] [Full Text] [Related]
10. Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue.
Connaughton M; Dabagh M
IEEE J Transl Eng Health Med; 2024; 12():413-434. PubMed ID: 38765886
[TBL] [Abstract] [Full Text] [Related]
11. Radix Actinidiae chinensis induces the autophagy and apoptosis in renal cell carcinoma cells.
Liu B; Yan Y; Zhang L
Eur J Med Res; 2024 May; 29(1):291. PubMed ID: 38764054
[TBL] [Abstract] [Full Text] [Related]
12. Risk Factors for Teicoplanin-Associated Acute kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin.
Morinaga Y; Tanaka R; Tatsuta R; Takano K; Hashimoto T; Ogata M; Hiramatsu K; Itoh H
Biol Pharm Bull; 2024; 47(5):988-996. PubMed ID: 38763761
[TBL] [Abstract] [Full Text] [Related]
13. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib.
Lin Z; Xiao S; Qi Y; Guo J; Lu L
J Cancer Res Clin Oncol; 2024 May; 150(5):262. PubMed ID: 38762825
[TBL] [Abstract] [Full Text] [Related]
14. Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients.
Fu Y; Zhong J; Tan Y; Zheng T; Liu M; Wang G
Sci Rep; 2024 May; 14(1):11409. PubMed ID: 38762673
[TBL] [Abstract] [Full Text] [Related]
15. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract] [Full Text] [Related]
16. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.
Mousavi SE; Najafi M; Aslani A; Fazlollahi A; Yekta Z; Sadri M; Nejadghaderi SA
Sci Rep; 2024 May; 14(1):11294. PubMed ID: 38760399
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
18. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
Loggenberg S; Twilley D; Lall N
J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
[TBL] [Abstract] [Full Text] [Related]
19. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
Janhunen O; Jokelainen O; Peltoniemi R; Nykopp TK; Arponen O
Acta Oncol; 2024 May; 63():330-338. PubMed ID: 38745483
[TBL] [Abstract] [Full Text] [Related]
[Next]
